Faculty of Medicine Asst. Prof. Dr. Hakan Darıcı's project, "Development of an Mesenchymal Stem Cell Exosome-Based, Targeted, Anti-Inflammatory and Anti-Viral Agent via CRISPR/Cas13 Method for the Treatment of COVID-19 and Similar Viral Diseases" has been granted within the scope of TÜBİTAK 1001 Scientific and Technological Research Projects Funding Program.